Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Correct there are a certain percentage of investors and even some whales who while watching house of the dragon will say to themselves, let me check if any stock has the word dragon, and a certain percentage will buy the stock, this also applies to holidays, astrology, ticker symbol code (V for ‘22 for example, DRGV) etc, if the attorney letter is not filed that is a missed opportunity, the company should have PRs around that timeframe to take advantage of the natural interest in a word associated with their stock, works like free advertising, hitch a ride on it and profit greatly.
Shouldn’t be any sustained downturn other than technical consolidations in any legit EV stock during a global energy crisis, no refineries planned to be built anywhere,
4:30p ET 6/1/2022 - Benzinga
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treating brain health. They do so by leveraging clinical data in order to achieve the best results possible.
Entheon Biomedical Corp. (OTCQB: ENTBF) is a wholly-owned subsidiary of HaluGen Life Sciences Inc., a company that has developed a DNA testing and personalized psychedelic pre-screening platform that provides genetic, personal and familial insights to better inform the psychedelic experience, improving patient care while reducing side effects and risk. Therefore, HaluGen's genetic-based platform helps evaluate an individual's overall sensitivity and risk profile when using hallucinogenic drugs with test results within days.
Both companies have combined their efforts and the result is a new expanded psychedelics genetic testing panel for Ehave's subsidiary psychedelics company, KetaDASH. The device will analyze a series of relevant DNA biomarkers and use pre-screening mental health surveys to understand a given individual's risk and potential of adverse reactions with the use of ketamine.
The new device will provide results that will be, then, absolutely personal.
On the other hand, genetics can play a key role in determining how an individual may respond to psychedelic-assisted psychotherapy. Specifically, the gene mutation CYP2B6 can influence the metabolism of ketamine for the 10-20% of people that carry a specific variant. Similarly, the HTR2A gene mutation, present in nearly 20% of the population, can impact how a person responds to serotonin, which is the primary mechanism of action for serotonergic psychedelics such as psilocybin, LSD and DMT.
It is expected that precision medicine will provide KetaDASH with the ability to tailor the treatment based on an individual or sub-groups variability in genes and lifestyle choice.
As Ehave CEO Ben Kaplan put it, "The benefit of the psychedelic profile is that it will enable the individuals and healthcare professionals at KetaDASH to personalize psychedelic therapy by providing an individual's metabolic status for ketamine with their CYP2B6 genotype."
This is a point of view shared by Entheon CEO Timothy Ko. "We believe that personalization will become an increasingly important feature of the psychedelic therapeutics landscape."
Photo Courtesy of Pixabay
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.“
4:30p ET 6/1/2022 - Benzinga
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treating brain health. They do so by leveraging clinical data in order to achieve the best results possible.
Entheon Biomedical Corp. (OTCQB: ENTBF) is a wholly-owned subsidiary of HaluGen Life Sciences Inc., a company that has developed a DNA testing and personalized psychedelic pre-screening platform that provides genetic, personal and familial insights to better inform the psychedelic experience, improving patient care while reducing side effects and risk. Therefore, HaluGen's genetic-based platform helps evaluate an individual's overall sensitivity and risk profile when using hallucinogenic drugs with test results within days.
Both companies have combined their efforts and the result is a new expanded psychedelics genetic testing panel for Ehave's subsidiary psychedelics company, KetaDASH. The device will analyze a series of relevant DNA biomarkers and use pre-screening mental health surveys to understand a given individual's risk and potential of adverse reactions with the use of ketamine.
The new device will provide results that will be, then, absolutely personal.
On the other hand, genetics can play a key role in determining how an individual may respond to psychedelic-assisted psychotherapy. Specifically, the gene mutation CYP2B6 can influence the metabolism of ketamine for the 10-20% of people that carry a specific variant. Similarly, the HTR2A gene mutation, present in nearly 20% of the population, can impact how a person responds to serotonin, which is the primary mechanism of action for serotonergic psychedelics such as psilocybin, LSD and DMT.
It is expected that precision medicine will provide KetaDASH with the ability to tailor the treatment based on an individual or sub-groups variability in genes and lifestyle choice.
As Ehave CEO Ben Kaplan put it, "The benefit of the psychedelic profile is that it will enable the individuals and healthcare professionals at KetaDASH to personalize psychedelic therapy by providing an individual's metabolic status for ketamine with their CYP2B6 genotype."
This is a point of view shared by Entheon CEO Timothy Ko. "We believe that personalization will become an increasingly important feature of the psychedelic therapeutics landscape."
Photo Courtesy of Pixabay
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
“9:03a ET 5/23/2022 - Benzinga
Borqs Technologies Announces Partnership With SkyCentrics To 'develop the Next Generation of CTA-2045 Smart Control Products for use by Solar Companies for "Electrification of Everything"'
Borqs Technologies, Inc. (NASDAQ:BRQS, ", Borqs", , or the ", Company", )))), a global provider of 5G wireless solutions, Internet of Things (IoT) solutions, and innovative clean energy, with global operations in the U.S., India and China, today announced that it has formed a strategic partnership with SkyCentrics to develop CTA-2045 ECOPORT products for use by solar companies in the push by many U.S. city and county governments for the "Electrification of Everything" programs. The partnership includes joint research & development, sales and promotion, as well as Borqs' investment into SkyCentrics. It will leverage Borqs' expertise in mobile IoT and 5G technologies. Borqs has years of manufacturing experiences in making products in China and outside China, and has manufactured products for the U.S. mobile operators and Fortune 500 companies. SkyCentrics is an expert in the CTA-2045 ECOPORT and will be responsible for the CTA-2045 software, ECOPORT certification and cloud functionality with its Demand Response Energy & Asset Management (DREAM) platform.
The products will be used in Borqs solar plus energy storage systems subsidiary Holu Hou Energy LLC (HHE). These units will also be used by utility companies in grid interactive water heater programs in the U.S.
The next generation of CTA-2045 will enhance the functionality of SkyCentrics' current mobile connected and Wi-Fi CTA-2045 ECOPORT devices with further cost reduction, which will make the CTA-2045 products more popular.
A smart city uses various types of electronic methods and sensors to collect data to gain insights in the management and operation of grid loads in order to improve efficiency and effectiveness. As a start in the development of a smart city, mobile connected CTA-2045 devices are chosen by utility companies across the U.S. as the platform for smart management of water heaters. Currently, all water heaters are â??dumb,' controlled by a thermostat and randomly going on and off. Smart and connected CTA-2045 controls can optimize the on/off schedule based on each household's usage pattern, grid prices and carbon emissions. It is estimated that the energy savings as well as carbon emission reduction by CTA-2045 controlled residential water heaters can produce staggering results, with each one million CTA-2045 equipped water heaters equating to the removal of 100,000 gasoline powered cars from the highways.
Early adoption of CTA-2045 EcoPort enabled water heaters has been underway in low-income multi-family solar and storage communities in Hawaii. Commercial and residential markets in buildings and power grid optimization can reach $154 billion by the year 2026, according to Verified Market Research in their study "Global Building Automation System Market Size By Technology, By System, By Application, By Geographic Scope And Forecast (Aug 2020)."
SkyCentrics is working with major commercial building industrial equipment manufacturers to provide them retrofit kits that will enable their embedded base of existing equipment to be retrofit to have a CTA-2045 EcoPort which will provide an inexpensive way to create the Grid Interactive Efficient Buildings (GEBs) that were recently promoted by the Biden administration quoting the "National Roadmap for Grid Interactive Efficient Buildings" report by The Lawrence Berkeley National Lab and The Brattle Group.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.“
Worldwide Energy Crisis and there are energy companies with solutions, partnerships and contracts.
This is now in effect:
“ This prospectus relates to the offer and sale of up to 6,650,000 shares (the “Resale Shares”) of Class A common stock (the “Class A Common Stock”) of which (i) 150,000 shares of Class A Common Stock (the “2022 Commitment Shares”) were issued pursuant to a Securities Purchase Agreement (the “2022 Securities Purchase Agreement”) that we entered into on April 15, 2022 with the selling shareholder named herein (the “Selling Shareholder”), (ii) 6,500,000 shares of Class A Common Stock are issuable upon the conversion of amounts outstanding (including principal and accrued interest thereon) under (a) convertible notes (the “2022 Convertible Notes”) issued pursuant to the 2022 Securities Purchase Agreement and (b) convertible notes (the “2021 Convertible Notes” and together with the 2022 Convertible Notes, the “Convertible Notes”) issued pursuant to a Securities Purchase Agreement (the “2021 Securities Purchase Agreement”) that we entered into on October 12, 2021 with the selling shareholder named herein.
We will not receive any proceeds from the sale of the Resale Shares by the Selling Shareholder. We will pay the expenses associated with the sale of securities pursuant to this prospectus.
We are registering the Resale Shares pursuant to the Selling Shareholder’s registration rights under a registration rights agreement between us and the Selling Shareholder. Our registration of the Resale Shares does not mean that the Selling Shareholder will sell any of the securities offered hereby. The Selling Shareholder may offer and sell the Resale Shares in a number of different ways and at varying prices. We provide more information about how the Resale Shares may be sold in the section entitled “Plan of Distribution.””
Macd on 6 month chart broke lower, share price would need to be sideways for a few days in the .03 to .05 so the macd doesn’t dive below the zero line, otherwise it may retest .005
“ Item 8.01. Other Events.
As previously disclosed in the Current Report on Form 8-K filed on March 30, 2022 by Sysorex, Inc. (“Company”), on March 24, 2022, the Company executed a Heads of Terms (“Heads of Terms”) with Ostendo Technologies, Inc. (“Ostendo”), which includes certain binding and non-binding provisions. Pursuant to the Heads of Terms, the Company and Ostendo agreed to certain terms related to the Company’s sale of a portion of its Ethereum mining assets and certain associated real property to Ostendo, subject to the terms of the Heads of Terms, and subject to definitive terms to be set forth in definitive transaction agreements to be executed by the parties. Pursuant to the terms of the Heads of Terms, the closing of the transaction was to occur no later than May 24, 2022, unless mutually extended in writing by the parties. As of May 31, 2022, the Company and Ostendo are negotiating an amendment to the Heads of Terms that would, among other things, have the effect of extending the Closing date. The Company expects that the amendment will be signed by the parties in the near future.”
-From yesterday’s 8-k
Negotiations can take weeks which would still fall into the category of “near future”. If the terms of the negotiation’s would be favorable for shareholders they would have said that in the 8-k.
One week to go till dip and rip possibility
Cenn to replace Tesla as Musk focuses on Twitter and is frustrated by self-driving tech issues, same as with the original Tesla, all his scientific work was taken by the US Cenntral government, the progression of the same story told with new characters, CENN 1000.00 per share one day in the future, world transitioning to EV (5 ‘22)(May, 2022).
Major chart opportunity higher begins now
.38 chart gap, if filled would run much higher would bring in investors that pay attention to gaps
Going back to 1.61 to fill all Chart gaps before winter surge higher I think
Block trades of smaller firms causing a 5 day consolidation zone could see 1.14 before Matrix news in the few days in this zone
Big day possible chart pattern very bullish for today’s candle
Yup .06 cup and handle minimum on news, then we’ll see what they do with the product, somebody sell a small amount at open to avoid the gap on news
$VEEE Twin V Power Cats in the year of the Tiger , the lead horse first to market and lead innovator in the niche
Everyday the world wakes up desperate for innovative energy solutions, the time is now
Jorff June let’s see if that resource estimate can send the stock to the moon
Graybug Junebug, this could be an amazing month if preliminary data is released
Trying to close at 80.01 on the Williams %R then turn higher as iron batteries demand increases with ban on Russian oil imports. This stock can be 30, 40 dollars a share in anticipation and 10x higher when it begins to exclusively solve or lead the world in providing massive amounts of energy via a a more abundant resource than lithium..
15 weeks to go
8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis
Countdown to potential billions in revenue.
Compare what happened when $MDMP announced how much oil they had under the ground (.01 to 1.00 in a few days) to what this legitimate company may have in lithium as the world hastens its transition to EV cars.
Share price holding up based on the mid-term value, and maybe surprise news along the way
VEEE the Tesla of electric boats, boating season and the letter V for 22, they are building up production and major investments should start to flow in as their efforts are recognized.
“Shares Outstanding as of Second Most Recent Fiscal Year End:
Opening Balance
Date 08/31/19
Common: 739,071,919
Preferred: 900,000
*Right-click the rows below and select “Insert” to add rows as needed.
Date of Transaction
Transaction type (e.g. new issuance, cancellation, shares returned to treasury)
Number of Shares Issued (or cancelled)
Class of Securities
Value of shares issued ($/per share) at Issuanc e
Were the shares issued at a discount to market price at the time of issuance? (Yes/No)
Individual/ Entity Shares were issued to (entities must have individual with voting / investment control disclosed).
Reason for share issuance (e.g. for cash or debt conversion)
-OR- Nature of Services Provided
Restricted or Unrestricted as of this filing.
Exemption or Registration Type.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) Page 4 of 18
5/06/21
New issuance
1
Special Preferred
.001
No
SSM Monopoly Corporation (Kareem Mansour)
Establish control of shell company
Restricted
144
05/07/21 05/07/21
10/01/21 10/06/21 10/28/21 11/23/21
Reverse Reduced Split 900,000
Reverse Reduced Split 600,000
New 41,341,3 Issuance 41
New 43,404,2 Issuance 72
New 45,570,1 Issuance 47
New 44,675,6 Issuance 88
Preferred Preferred
Common Common Common Common
.001 N/A .001 N/A
.0061 No 275
.0077 No 52
.006 No
.0054 No 15
J. Christopher Mizer
Steve Scholl
SBI Investments
SBI Investments
SBI Investments
SBI Investments
Decision of Custodian
Decision of Custodian
Conversion of Debt Instrument Conversion of Debt Instrument Conversion of Debt Instrument Conversion of Debt Instrument
Unrestrict ed
Unrestrict ed
Unrestrict ed
Unrestrict ed
Unrestrict ed
Unrestrict ed
5MMto1 Adjustme nt 5MMto1 Adjustme nt
5/27/21
New Issuance
50,036,4 28
Common
.001
Yes
Old Main Capital, LLC (Eric Rogers)
Conversion of Debt Instrument
Unrestrict ed
9/17/21
New Issuance
39,376,4 55
Common
.0054 24
SBI Investments
Conversion of Debt Instrument
Unrestrict ed
No
Shares Outstanding on Date of This Report: Ending Balance Date: 02/28/22
Common: 1,003,475,250
Preferred: 1”
https://www.otcmarkets.com/otcapi/company/financial-report/327637/content
Strong chart and Vegas app is legit and can create opportunities elsewhere to encourage people to visit locations and collect NFTs etc for exploration of an area, a modernized treasure app, very strong opportunity here.
“Remark Holdings Launches VegasVerz, an Augmented and Virtual Reality App Powered by Remark AI in Conjunction with Upcoming BTS Las Vegas Concerts April 8-9, 2022 and April 15-16, 2022
Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence ("AI") solutions and digital media properties, announced today that it has launched VegasVerz, an Augmented and Reality App Powered by Remark AI in conjunction with the upcoming BTS Shows in Las Vegas April 8-9, 2022 and April 15-16, 2022. VegasVerz delivers the complete Las Vegas BTS Fan Experience, incorporating augmented and virtual reality to create an enjoyable and discoverable adventure that allows fans to collect unique items including NFTs, while participating in special one-of-a-kind experiences in Las Vegas.
Anchored by MGM Resorts International's (NYSE: MGM) properties, which will serve as headquarters for the BTS Fan Army, the VegasVerz App allows fans to explore the world of BTS and collect unique virtual treasures that can be redeemed for discounts and opportunities, by exploring Bellagio, ARIA, MGM Grand, Mandalay Bay, Luxor, Excalibur, and The Mirage, which have all been enhanced by augmented reality.
The VegasVerz App is now available in the Apple App Store (VegasVerz App) and Google Play Store (VegasVerz App).
Shing Tao, Chairman and CEO of Remark Holdings, said, "Remark AI is proud to bring our augmented and virtual reality expertise to a global audience anchored by the BTS Army and MGM Resorts. We first showcased our technology at the Winter Olympics in Beijing 2022 and in partnership with Infinite Prospects Entertainment will continue our footprint into building augmented and virtual experiences for iconic events around the world. This is only the first few steps in showcasing how we continue to leverage our AI platform."
https://www.prnewswire.com/news-releases/remark-holdings-launches-vegasverz-an-augmented-and-virtual-reality-app-powered-by-remark-ai-in-conjunction-with-upcoming-bts-las-vegas-concerts-april-8-9-2022-and-april-15-16-2022-301520965.html
“Following the commercial production, Else will conduct clinical trials to validate product safety and benefits for regulatory approval of its infant formula, which is anticipated to become the Company's flagship product.”
Clinical trials starting may be a buy, when though is the question.
Pink Limited Information
Verified Profile IconVerified Profile 02/2022
Transfer Agent Verified
Gaps exist at .001, .076 and .1140
From “Quarterly Report (10-q)
May 23 2022”:
In actual dollars:
Net (Loss) Income $ (3,033.000)
Total Assets $. 20,671,000
Total Current Liabilities $ 33,469,000
And:
“Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:
? our ability to successfully integrate acquired businesses or new products, or to realize anticipated synergies in connection with mergers and acquisitions.
? the effect of COVID-19, closure of offices and site location(s); on our ability to service our customers resulting in less revenues;
? our cash position and our history of losses.
? our ability to achieve profitability.
? customer demand for the products and services we offer.
? the impact of competitive or alternative services, products, technologies, and pricing.
? increased delays in delivery of product due to worldwide strain on supply chain primarily due to labor, raw material, and chip shortages.
? general economic conditions and events and the impact they may have on us, on our customers, and on our potential customers.
? a security breach, through cyber-attack, cyber intrusion, insider threats or otherwise, or other significant disruption of our IT networks and related systems.
? decrease in value of digital assets
? general cryptocurrency risks.
? technological changes and developments in the blockchain and cryptocurrencies.
? risks related to changes of rules and regulations in connection with cryptocurrencies in general and Ethereum in particular.
? risks related to Ethereum’s transition from “proof-of-work” to “proof-of-stake” model that may render mining activities within Ethereum blockchain obsolete.
? risks related to the loss of assets of our cryptocurrency mining facility held with a third party.
? competition for blockchain platforms and technologies, including but not limited to non-fungible tokens (“NFTs”);
? our ability to obtain adequate financing in the future.
? our ability to continue as a going concern.
? our ability to complete strategic transactions, which may include acquisitions, mergers, dispositions, joint ventures, or investments.
? lawsuits and other claims by third parties
? the restatement of our financial statements in our Annual Report on Form 10-K/A for the fiscal year ended December 31, 2021, and the impact of such restatement on our future financial statements and other financial measures; and the material weaknesses we identified in our internal control over financial reporting, our efforts to remediate such material weaknesses and the timing of remediation
? our success at managing the risks involved in the foregoing items.
? authorized shares will be insufficient to convert debenture holders; and
? other factors discussed in this report.
The forward-looking statements are based upon management’s beliefs and assumptions and are made as of the date of this report. We undertake no obligation to publicly update or revise any forward-looking statements included in this report. You should not place undue reliance on these forward-looking statements.“
https://ih.advfn.com/stock-market/USOTC/sysorex-qb-SYSX/stock-news/88187330/quarterly-report-10-q
Bullish Investors are banking on Ostendo news coupled with the inability to convert the debenture holders to cause a spike.
“8:00p ET 5/30/2022 - Globe Newswire
Fobi To Host Shareholder Update Call To Discuss Q3 Results And Operational Highlights
EQNX::TICKER_START (TSX-V:FOBI),(OTC US:FOBIF),(Other OTC:FOBIF), EQNX::TICKER_END Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), a leading data intelligence company using artificial intelligence to help clients turn real-time data into actionable insights and personalized customer engagement is pleased to announce its third-quarter (January 1st, 2022 to March 31st, 2022) Financial and Operational Highlights for Q3.
Fobi will hold a Webinar to explain the Q3 Financial Results on Wednesday June 01, 2022 at 9:00am PST”
The word “logistics” is in tens of thousands of company names and is relevant to the supply chain which Fobi’s products can assist in facilitating:
“8:00a ET 4/29/2022 - Globe Newswire
Fobi Incorporates And Launches New Wholly Owned Subsidiary PulseIR
Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), a leader in providing real-time data analytics through artificial intelligence to drive customer and investor activation and engagement, announces the launch of its wholly owned subsidiary PulseIR. PulseIR will not only provide a new data driven and mobile approach to Investor Relations with Fobi's recently launched Investor Pass product, however PulseIR will also offer and further provide a full suite of custom managed and contract services and additional product offerings. PulseIR will earn revenue from annual license fees, marketing and contract development service fees, media advertising & sponsorship and referral fees.
Fobi is launching PulseIR to support the company's latest product, an investor relations platform and it's release of the Investor Experience, which is a multi-faceted and data driven communication and marketing platform that leverages the power of Fobi's AI, Big Data and Mobile Wallet Technology. This powerful trio of applications and functionalities will help public companies convert their unknown investors into known investors while being able to engage and improve on their investor relations strategies and communications through the delivery of real time, personalized shareholder communications.
Fobi VP of Marketing Ian Cameron stated: "PulseIR provides a means to leverage data to create a better understanding of who your investors are and a means to create more personalized, relevant and meaningful communications and engagement. Furthermore, the launch of PulseIR is extremely well-timed as companies struggle with the current challenges in regards to labour shortages and of course the extreme rise in costs of staffing. We will be providing a complete one-stop shop if you will by offering the necessary tools and expertise with our fully managed and contract services."
WATCH HOW FOBI IS LEVERAGING THE POWER OF AI, BIG DATA AND MOBILE WALLET TECHNOLOGY TO RAISE THE BAR FOR INVESTOR RELATIONS IN THIS LIVE DEMO OF THE FOBI INVESTOR EXPERIENCE PASS. THE LINK TO THE WEBINAR IS HERE.
Here is a look into the data that has been collected from the Investor Passes downloaded in the last 48 hours:
502 Total downloads.
95% filled out the survey section.
Males made up 87% of investor participants.
40-50 was the largest age demographic.
17% of the downloads were by Accredited Investors.
81% of them have a long-term investment strategy.
$50,000-$250,000 was the average portfolio size selected.
Energy was selected as the highest level of interest outside of the tech sector.
Fobi CEO Rob Anson stated: "These are very exciting times for us as we continue to drive innovation and deliver transformative solutions across various industries. With today's launch of PulseIR, we believe it puts us in a very strong position to further add great value in the form of various new lines of revenue. Our goal is to assist in transforming and raising the bar for all stakeholders involved in investor relations and the capital markets world."
LISTEN TO FOBI CEO ROB ANSON AS HE JOINS DEV SEIDEL FOR THE FOBI INSIDER PODCAST
The Podcast episode can be found here.
For more information on PulseIR please visit www.pulseir.com.
This Press Release Is Available on the FobiWebsite,as well as the FOBI Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement.”
“The town said they don’t know him and he’s never worked there.” Why ask if he ever worked there, I stated that someone with the same last name worked there. What a coincidence, a Wall Street affiliated person changed the name to Moon Equity Holdings and failed at a Peru deal on purpose in plausibly deniable fashion likely as a delay tactic story that for some time increased the share price and allowed for the company to dump shares and fund bitgift’s creation for Frank, who owns Moon Crypto Card Trademark, imo that was the plan all along and that tells me that bitgift might actually be a legit product this year. It will take the next 6 months to build that trust and credibility in the product before holiday shopping season. Maybe by then crypto will turn higher also, perfect storm possible in December, having that beacon of monetary hope out there in the relatively near term is a great story if they can market the product.
In my opinion yes, the person who called Moon Township asked them if Frank ever worked there, but that is clearly not what I stated, I clearly stated that someone with the same last name as Frank has worked there for years and was part of the chamber of commerce, too much of a coincidence not to be relevant, meaning that Frank was always the planned CEO and Alison was just the wall street step to get to Frank and bitgift. The only question after the cup and handle completes to .06 imo is “is bitgift legit” for the holidays which would bring it into the .70 to .80 SP by December shopping season with a few spikes along the way. Just how I project the SP to act, and I’ve already provided what I think IV should do with their restricted shares.
The world is in desperate need of energy sources as not enough refineries and no plans to build more. Globally, refineries were shut down during pandemic or are in the process of being refurbished, leaving a emergency void that alternate energy must fill as economies reopen and summer approaches. Further, Ukraine made a special wiring part for combustion engines leaving tremendous incentive to switch to EV quickly. Perfect storm for GWH’s technology to step in.
CEXPF Cache Exploration Inc. Expert Market
Failed at opportunity to be pink and mining by June 2022
Please reply to this if you see filings thanks
If 30 million shares owned by Imperative Ventures is erroneous then those shares would be subject to cancellation. Somehow I feel like the firm isn’t going to just hand over 30 million shares for free, unless they think their remaining shares will appreciate greatly by doing so because of the goodwill and perception amongst new investors that they simply aren’t paying Imperative Ventures money for a flat or decreasing shareprice in the near term while banking on long term bitgift success. Imperative could declare between now and tomorrow morning that their shares are locked until January 2023, appreciating their shares if bitgift is legit since they could then ask to be bought out of those shares at a discount for the company which presumably would be flush with cash profits but still a great profit for IV. Selling x amount of restricted shares every month and hoping people don’t notice isn’t a creative financial strategy imo. In fact another firm with vision and belief in bitgift should buy those restricted shares from IV for a 10% premium (400,000 buy for current value 370,000) and lock them, if IV isn’t a true believer in holiday sales opportunity. Invest 400,000 now for possible profit next year of 10x in that deal scenario.
.0032 gap exists
.0059 gap fill this week, then news
Could see share price increase Friday
Looking for 1.22 gap fill close Tuesday, then run on major news after hours or premarket Wednesday